315 related articles for article (PubMed ID: 25755521)
21. Update on liver transplantation-newer aspects.
Metin O; Şimşek C; Gürakar A
Turk J Med Sci; 2020 Nov; 50(SI-2):1642-1650. PubMed ID: 32222125
[TBL] [Abstract][Full Text] [Related]
22. Extended criteria donors in liver transplantation Part I: reviewing the impact of determining factors.
Nemes B; Gámán G; Polak WG; Gelley F; Hara T; Ono S; Baimakhanov Z; Piros L; Eguchi S
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):827-39. PubMed ID: 26838962
[TBL] [Abstract][Full Text] [Related]
23. Liver Transplant From Controlled Cardiac Death Donors Using Normothermic Regional Perfusion: Comparison With Liver Transplants From Brain Dead Donors.
Rodríguez-Sanjuán JC; Ruiz N; Miñambres E; Toledo E; González-Noriega M; Fernández-Santiago R; Castillo F
Transplant Proc; 2019; 51(1):12-19. PubMed ID: 30655135
[TBL] [Abstract][Full Text] [Related]
24. Hypothermic Machine Perfusion Results in a Marginal Kidney Transplant Programme.
Gómez-Dos Santos V; Ruiz Hernández M; Burgos-Revilla FJ
Eur Urol Focus; 2018 Mar; 4(2):163-168. PubMed ID: 29929872
[TBL] [Abstract][Full Text] [Related]
25. Living donor liver transplantation for hepatocellular carcinoma.
Lee SG; Moon DB
Recent Results Cancer Res; 2013; 190():165-79. PubMed ID: 22941020
[TBL] [Abstract][Full Text] [Related]
26. Factors affecting graft survival after liver transplantation from donation after cardiac death donors.
Lee KW; Simpkins CE; Montgomery RA; Locke JE; Segev DL; Maley WR
Transplantation; 2006 Dec; 82(12):1683-8. PubMed ID: 17198260
[TBL] [Abstract][Full Text] [Related]
27. Outcomes of liver transplantation using moderately steatotic liver from donation after cardiac death (DCD).
Duan X; Yan L; Shen Y; Zhang M; Bai X; Liang T
Ann Transl Med; 2020 Sep; 8(18):1188. PubMed ID: 33241037
[TBL] [Abstract][Full Text] [Related]
28. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool.
Selck FW; Grossman EB; Ratner LE; Renz JF
Ann Surg; 2008 Oct; 248(4):599-607. PubMed ID: 18936573
[TBL] [Abstract][Full Text] [Related]
29. Extended donors in liver transplantation.
Harring TR; O'Mahony CA; Goss JA
Clin Liver Dis; 2011 Nov; 15(4):879-900. PubMed ID: 22032534
[TBL] [Abstract][Full Text] [Related]
30. Living donor liver transplantation.
Jeon H; Lee SG
Curr Opin Organ Transplant; 2010 Jun; 15(3):283-7. PubMed ID: 20489627
[TBL] [Abstract][Full Text] [Related]
31. Outcomes Using Grafts from Donors after Cardiac Death.
Doyle MB; Collins K; Vachharajani N; Lowell JA; Shenoy S; Nalbantoglu I; Byrnes K; Garonzik-Wang J; Wellen J; Lin Y; Chapman WC
J Am Coll Surg; 2015 Jul; 221(1):142-52. PubMed ID: 26095563
[TBL] [Abstract][Full Text] [Related]
32. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
33. Prevention of hepatitis B virus infection from hepatitis B core antibody-positive donor graft using hepatitis B immune globulin and lamivudine in living donor liver transplantation.
Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
Liver Int; 2005 Dec; 25(6):1169-74. PubMed ID: 16343068
[TBL] [Abstract][Full Text] [Related]
34. Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.
Jesudian A; Desale S; Julia J; Landry E; Maxwell C; Kallakury B; Laurin J; Shetty K
J Clin Exp Hepatol; 2016 Jun; 6(2):109-14. PubMed ID: 27493458
[TBL] [Abstract][Full Text] [Related]
35. Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation.
Crismale JF; Ahmad J
World J Gastroenterol; 2019 Dec; 25(47):6799-6812. PubMed ID: 31885421
[TBL] [Abstract][Full Text] [Related]
36. Organ donation and transplantation in the UK-the last decade: a report from the UK national transplant registry.
Johnson RJ; Bradbury LL; Martin K; Neuberger J;
Transplantation; 2014 Jan; 97 Suppl 1():S1-S27. PubMed ID: 24356460
[TBL] [Abstract][Full Text] [Related]
37. Risk of extended criteria donors in hepatitis C virus-positive recipients.
Berenguer M
Liver Transpl; 2008 Oct; 14 Suppl 2():S45-50. PubMed ID: 18825715
[TBL] [Abstract][Full Text] [Related]
38. Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases.
Hong JC; Yersiz H; Farmer DG; Duffy JP; Ghobrial RM; Nonthasoot B; Collins TE; Hiatt JR; Busuttil RW
J Am Coll Surg; 2009 May; 208(5):682-9; discusion 689-91. PubMed ID: 19476815
[TBL] [Abstract][Full Text] [Related]
39. Outcome of organs procured from donors on extracorporeal membrane oxygenation support: an analysis of kidney and liver allograft data.
Carter T; Bodzin AS; Hirose H; West S; Hasz R; Maley WR; Cavarocchi NC
Clin Transplant; 2014 Jul; 28(7):816-20. PubMed ID: 24805948
[TBL] [Abstract][Full Text] [Related]
40. Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors.
Cotter TG; Paul S; Sandıkçı B; Couri T; Bodzin AS; Little EC; Sundaram V; Charlton M
Hepatology; 2019 Jun; 69(6):2381-2395. PubMed ID: 30706517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
